Kala Pharmaceuticals Inc

Stock Chart, Company Information, and Scan Results

$0.68(as of Dec 12, 3:34 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Kala Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$0.68
Ticker SymbolKALA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees38
CountyUSA
Market Cap$8.3M
EBIDTA-41.3M
10-Day Moving Average0.93
P/E Ratio-0.14
20-Day Moving Average0.80
Forward P/E Ratio0.00
50-Day Moving Average0.96
Earnings per Share-5.64
200-Day Moving Average5.41
Profit Margin-Infinity%
RSI36.23
Shares Outstanding10.7M
ATR0.25
52-Week High20.60
Volume2,824,260
52-Week Low0.61
Most Recent Support Level0.75
Book Value23.9M
Most Recent Resistance Level0.86
P/B Ratio0.20
Upper Keltner1.37
P/S Ratio19.26
Lower Keltner0.24
Debt-to-Equity Ratio1.37
Next Earnings DateUnknown
Cash Surplus-11.5M
Next Ex-Dividend DateUnknown

KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

Kala Pharmaceuticals Inc In Our Stock Scanner

As of Dec 12, 2025
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Bull FlagScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.